在修改后的弗里德里希的性衰竭评分尺度中的域特异性安慰剂反应
Christian Rummey1, Jennifer M Farmer2, David R Lynch3
1Clinical Data Science GmbH, Basel, Switzerland.
Annals of clinical and translational neurology
|November 26, 2025
概括
在弗里德里希心症试验中,安慰剂反应主要影响四肢功能,而不是核心轴功能. 这一发现影响了临床试验设计和对性衰竭研究的终点选择.
科学领域:
- 神经学 神经学
- 临床试验 临床试验
- 亚动力学研究 亚动力学研究
背景情况:
- 临床试验中安慰剂反应复杂化了结果的解释.
- 真正的治疗效果可能会被安慰剂效应所掩盖.
研究的目的:
- 为了分析过去的弗里德里希心症试验中的安慰剂组数据.
- 调查弗里德里希心症研究中安慰剂反应的性质和影响因素.
主要方法:
- 从历史的弗里德里希无氧试验中分析安慰剂组数据.
- 使用修改后的弗里德里希性衰竭评分表 (mFARS) 底值评估尾和轴功能变化.
- 评估测试频率,间隔和参与者年龄对安慰剂反应的影响.
主要成果:
- 在mFARS的尾 (四肢) 功能子标记中观察到显著的安慰剂反应.
- 在轴函数子值中检测到最小的变化.
- 安慰剂反应强度与连续测试的数量,测试间隔较短,参与者年龄较大等积极相关.
结论:
- 在弗里德里希氧试验中的安慰剂效应主要在附录测量中观察到.
- 直立稳定性评分 (USS) 是mFARS的子评分,由于其独特的响应模式,它显示出作为独立结果衡量的潜力.
- 这些发现需要仔细考虑试验设计和终点选择,以减轻安慰剂效应干扰.
相关概念视频
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


